content

Roche’s Antibody Cocktail is now available in India, Cipla to market it pan-India

Roche India and Cipla Limited announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a...

AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan

AstraZenecaโ€™s COVID-19 vaccine, Vaxzevria (ChAdOx1-S ), formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals...

Moderna Reports Positive COVID-19 Vaccine Results in Adolescents

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in...

CanSino Biologics Gets OGYEI GMP Certificate for COVID Vax

CanSino Biologics Recombinant Novel Coronavirus Vaccine, (Adenovirus Type 5 Vector, trade name Convidecia), has been granted a Good Manufacturing Practice certificate by the Hungarian...

UPS Healthcare Accelerates Cold Chain Capabilities

UPS is expanding its specialty pharmaceutical offerings by establishing UPS Cold Chain Solutions, a comprehensive suite of cold chain technologies, best-in-class capabilities, and new...

ANVISA Sorrento Phase 2 Pivotal Clinical Trial of COVI-MSC in Hospitalized COVID-19 Patients With Acute Respiratory Distress Syndrome

Sorrento Therapeutics, Inc. announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed with a Phase 2 Pivotal clinical trial of COVI-MSCโ„ข,...

The Future of Tech in Nutraceuticals Industry

Nutrify Today, Indiaโ€™s first and only nutraceuticals i2C (ideas to commercialization) platform has been engaging and empowering the responsible nutrition industry through knowledge, connections,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read